Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Can Oncol Today. 2025;2(1):13–17. doi:10.58931/cot.2025.2131